Modern Poultry Media
subscribe
Facebook-f Linkedin-in
translate
Search

MENU

Search
Facebook-f Linkedin-in
subscribe
translate
Boehringer Ingelheim Animal Health

Interview: Understanding immunosuppression in poultry — and how to manage it

Immunosuppression is a costly yet often misunderstood problem in the poultry industry. But what exactly is immunosuppression, and how can it be detected, diagnosed and measured? In the first of a two-part series, Isabel Gimeno, DVM, PhD, and Bill Stanley, DVM, share their expertise on this topic.

Category: Boehringer Ingelheim

Improving poultry vaccine supply: Inside the manufacturing process

Behind every successful poultry operation is a dependable vaccine supply chain. But producing vaccines is no small feat — it requires precision, foresight and the ability to adapt to biological and regulatory challenges. Daniel Hamby, senior associate director of manufacturing science and technology at Boehringer Ingelheim, gives a behind-the-scenes look at vaccine production and explains what it takes to deliver consistent, high-quality products to the industry.

More from Boehringer Ingelheim

How data-driven insights are reshaping flock management

Data is playing a growing role in helping producers manage risk, optimize health and justify production decisions. From digitizing information to store it securely to using it to guide real-time decision-making, for Dan Wilson, DVM, founder of Wilson Veterinary Co., it has become integral to the way he works with producers to improve flock performance.

Flocks vaccinated in ovo with HVT and CVI-LTR Marek’s vaccine show more immunity at hatch

Abstract: Effect of MDV-1 vaccines administered alone or with HVT on the development of the chicken embryo immune system

Import license for avian metapneumovirus vaccine offers new tool for producers

Faced with the emerging disease threat posed by avian metapneumovirus (aMPV), the USDA is allowing the importation of three vaccines from Boehringer Ingelheim: the live virus products NEMOVAC™ for use in chickens and AVIFFA RTI for use in turkeys and chickens, as well as the TUR-3 inactivated vaccine for primary vaccination of both turkey and chicken flocks against aMPV subtype B.

Beyond protection: How vaccines are shaping the poultry microbiome

The poultry gut is more than just a digestive organ — it’s a dynamic ecosystem that plays a critical role in bird health, disease resistance and overall performance. As the industry continues moving beyond blanket antibiotic use, producers and researchers alike are zooming in on the gut microbiome and how to manage it more effectively.

How immunosuppression and secondary pathogens increase aMPV threat to US poultry

The emergence of aMPV subtypes A and B has left US poultry producers seeking new tools to reduce the economic impact of this disease. In an interview, Silke Rautenschlein, PhD, professor at the University of Veterinary Medicine in Hannover, Germany, covers the past, present and future of the virus and its control.  

Vaccination innovation offers fresh hope against evolving Marek’s disease

An innovative vaccine designed to protect broilers against increasingly virulent forms of Marek’s Disease is helping producers rethink how they approach immune health, and how they use data to diagnose problems before they’re visible in the flock.

Coccidiosis control: Why vaccination wins — and how to do it right

Coccidiosis doesn’t just lurk in poultry houses — it thrives there. For decades, producers have relied on synthetic anticoccidials and ionophores to keep it in check. But with growing resistance and increasing pressure to reduce antibiotic use, more operations are turning to vaccination as a sustainable, effective alternative.

Struggling with flock health? Focusing on ‘Triad of Bird Immunity’ may improve outcomes

What is the best way to safeguard poultry health across a wide range of production systems and management teams? That’s a question Rick Phillips, DVM, MAM, director of poultry professional services veterinarians at Boehringer Ingelheim, has explored for more than 25 years while working with live-production teams across the US.

USDA authorizes Boehringer Ingelheim to import two live aMPV vaccines for emergency use

USDA has authorized Boehringer Ingelheim to import two of the company’s live-virus vaccines for emergency use to help protect US poultry against avian metapneumovirus (aMPV) — a highly contagious respiratory viral infection that can result in severe respiratory symptoms and increased mortality in poultry.

Interview: Optimizing vaccine performance in the field

Vaccines are essential tools for managing diseases in poultry and ensuring flock welfare. Taking shortcuts with them is never a good idea, however, and there’s plenty of research to prove it. In the second of a two-part series, Bill Stanley, DVM, and Isabel Gimeno, DVM, PhD, talked about their experiences managing vaccines and ensuring optimum performance.

Interview: Understanding immunosuppression in poultry — and how to manage it

Immunosuppression is a costly yet often misunderstood problem in the poultry industry. But what exactly is immunosuppression, and how can it be detected, diagnosed and measured? In the first of a two-part series, Isabel Gimeno, DVM, PhD, and Bill Stanley, DVM, share their expertise on this topic.

Boehringer Ingelheim introduces aMPV vaccine for US chickens, turkeys

USDA has given Boehringer Ingelheim the green light to import TUR-3, a killed vaccine currently licensed for use throughout Europe for Newcastle disease, avian paramyxovirosis type 3 and turkey rhinotracheitis.

Poultry scientist: Don’t overlook nutrition’s role in building a robust immune system

Is diet the rising X factor for optimizing immunity in poultry? Researchers at the Southern Poultry Research Group (SPRG) in Athens, Georgia, are building a strong case, via a growing body of research shedding new light on how diet influences the traditional pathogen-host-environment triangle for assessing disease risk.

Schat: Add the thymus to post-mortems for a thorough exam

Post-mortem examinations are essential for maintaining a comprehensive, targeted flock-health program. But when it comes to managing viral diseases, is it enough to look at the bursa?

Jackwood: Proper breeder vaccination, minimizing susceptibility window keys to preventing IBD immune suppression

The message is clear and one that Daral Jackwood, PhD, The Ohio State University, has delivered for years: Young chickens need maternal immunity to protect them from immunosuppression and secondary diseases caused by infectious bursal disease.

People are fomites, too: Leading swine veterinarian shares biosecurity lessons with poultry industry

Biosecurity is a continuous work in progress with protocols evolving over the years based on new research and experiences.

Hoerr: Building poultry flock immunity requires much more than vaccines

Virtually everyone involved with live poultry production knows the importance of protecting layer, breeder and broiler flocks against infectious bursal disease. If left unchecked, it can cause listlessness, watery diarrhea, ruffled feathers and dehydration.

Boehringer Ingelheim poultry coccidiosis vaccine returns to market with new name

Boehringer Ingelheim has announced the launch of Vaxxilive® Cocci 3, a poultry coccidiosis vaccine previously known as Hatchpak® Cocci III.

Modern Poultry is pleased to host
this editorial page on behalf of

Boehringer Ingelheim
Animal Health